Hostname: page-component-54dcc4c588-tfzs5 Total loading time: 0 Render date: 2025-10-01T07:26:09.194Z Has data issue: false hasContentIssue false
  • English
  • Français

Motivation for Sustained Substance Use in Patients with Psychotic Disorders

Published online by Cambridge University Press:  26 August 2025

C. Tapoi
C. Tapoi*
Affiliation:
Addictions Department, Alexandru Obregia Clinical Psychiatry Hospital, Bucharest, Romania

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Substance use is a prevalent issue in individuals with psychotic disorders and has major implications for the course of the disease. Substance use is associated with treatment noncompliance, more positive symptoms and increased risk of relapse. However, reasons for substance use in people diagnosed with psychotic disorders are insufficiently understood.

Objectives

This study seeks to explore the specific reasons for substance use among patients diagnosed with psychotic

disorder, while aiming to identify subgroups of patients that may benefit from targeted interventions to reduce drug use.

Methods

We investigated the reasons for maintaining substance use in patients with a dual diagnosis of psychotic disorder and substance use disorder that were admitted to Alexandru Obregia Clinical Psychiatric Hospital, Addictions Department, Bucharest, Romania, between October 2024 and March 2025. Patients were evaluated through a semi-structured interview developed for this study.

Results

The results of the study will be available and presented during the EPA 2025 Congress.

Conclusions

Understanding the underlying motivations for substance use is crucial for developing targeted interventions that address the unique needs of patients with psychotic disorders, ultimately improving treatment outcomes and promoting long-term recovery.

Disclosure of Interest

None Declared

Information

Type
Abstract
Information
European Psychiatry , Volume 68 , Special Issue S1: Abstracts of the 33rd European Congress of Psychiatry , April 2025 , pp. S480
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.